ProQR Therapeutics NV (PRQR) News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

​​UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549​FORM 6-K​Report of Foreign Private...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:April 24, 2023...

Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)

TABLE OF CONTENTS  Filed pursuant to Rule 424(b)(5)  Registration No...

Withdrawal of Registration Statement (rw)

  ProQR Therapeutics N.V.   Zernikedreef 9 2333 CK Leiden The Netherlands +31 88 166 7000   March 29...

Securities Registration (foreign Private Issuer) (f-3)

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on March 29, 2023...